222
-3
9
Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Browse Other Projects on Experiment
Related Projects
Can plant-based antimicrobials act as an alternative to therapeutic antibiotics?
Antibiotic overuse has led to antimicrobial resistance (AMR). The World Health Organisation (WHO) ranks...
How does taking Ritalin affect depersonalization-derealization disorder patients?
We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...
Nutritional analysis of cold-climate perennial vegetables
Perennial vegetables are edible plants that regrow in the same place every year. They are a key component...